Results 281 to 287 of about 619,494 (287)

Bufalin Inhibits the PI3K/AKT Pathway by Targeting GTF3C4 to Impede Breast Cancer Progression

Advanced Science, EarlyView.
Mechanisms of Bufalin‐Mediated Intervention in Breast Cancer. ABSTRACT Breast cancer incidence is rising globally, presenting challenges such as treatment side effects and drug resistance. Bufalin is a bufadienolides compound with potential anti‐cancer effects. This study shows that bufalin inhibits malignant proliferation of MDA‐MB‐231 and MCF‐7 cells
Siyu Guo, Xiaodong Chen, Haojia Wang, Jiying Zhou, Peiying Lu, Jiangying Liu, Keyan Chai, Jingyuan Zhang, Siyun Yang, Shan Lu, Yifei Gao, Zhengsen Jin, Xiaoyu Tao, Zhongdong Hu, Qinglin Li, Jiarui Wu   +15 more
wiley   +1 more source

Bioinformatics Analysis of Tumor-Associated Macrophages in Hepatocellular Carcinoma and Establishment of a Survival Model Based on Transformer. [PDF]

Int J Mol Sci
Zeng Z, Rao S, Zhang J.
europepmc   +1 more source

Tumor-associated macrophages: potential role in skeletal involvement in classic Hodgkin lymphoma. [PDF]

J Pathol Clin Res
Andersen MD, Wolter K, Enemark MH, Pedersen MA, Gormsen LC, Lauridsen KL, Starklint J, Hamilton-Dutoit SJ, d'Amore F, Ludvigsen M, Kamper P.   +10 more
europepmc   +1 more source

Tumor-infiltrating lymphocytes and tumor-associated macrophages in cancer immunoediting: a targetable therapeutic axis. [PDF]

Front Immunol
Mukherjee S, Ghosh A, Chakraborty S, Basak U, Mukherjee S, Das T, Sa G.   +6 more
europepmc   +1 more source

TAF15 in tumor-associated macrophages enhances protumorigenic polarization and promotes cholangiocarcinoma progression. [PDF]

JHEP Rep
Liu Y, Xu B, Zhao T, Liu H, Pan Y, Zhao S, Chen Q, Wang L, Bai G, Zhang N, Zhou Y, Wei J, Fu X, Zhou Y, Wang Z, Xu L, Zhu Y, Shen S, Yang S, Zhou L, Wang L.   +20 more
europepmc   +1 more source

Inhibiting SLAMF8 modulates tumor-associated macrophages and restores CD8+ T cell-mediated antitumor immunity in colorectal cancer. [PDF]

Oncoimmunology
Han X, Bai X, Wang N, Sun Y, Hu J, Li L, Liu Z, Zhang Y, Liang Z, Sang L, Han L, Zhang Q, Qian X.   +12 more
europepmc   +1 more source

GPR34 inhibition reprograms tumor-associated macrophages and enhances the sensitivity of anti-PD-1 therapy in hepatocellular carcinoma. [PDF]

Cancer Cell Int
Liu W, Yu Q, Liu X, Zhang F, Jiang Q, Tang W, Dong L.   +6 more
europepmc   +1 more source